Plains GP Holdings (PAGP) released its second quarter 2026 earnings on August 7, reporting higher sales of US$17,693 million and net income of US$389 million compared with the prior year period.
See our latest analysis for Plains GP Holdings.
The latest earnings release comes after a strong period for Plains GP Holdings, with a 35.5% year to date share price return and a 50.62% total shareholder return over the past year. This suggests momentum has been building as investors reassess both growth prospects and risk.
If strong midstream interest has your attention, this could be a good moment to widen your search and check out 39 power grid technology and infrastructure stocks
Plains GP Holdings now combines a sizeable midstream footprint with strong recent earnings and a sharp share price move. The key issue for you is whether the current market price already reflects that strength.
The most followed narrative for Plains GP Holdings places fair value at $24.14, which sits below the last close at $26.30. That gap is built on specific views about future cash generation and capital deployment.
The planned divestiture of the NGL segment and redeployment of ~$3 billion in proceeds into core crude oil operations and bolt-on acquisitions are expected to streamline operations, reduce commodity price exposure, and enhance financial flexibility, supporting growth in core revenue and improved net margins via higher-return investments and potential buybacks.
The fair value story for Plains GP Holdings leans heavily on faster revenue growth, fatter margins, and a much lower profit multiple in a few years. Curious which combination of earnings ramp up, margin shift, and valuation reset needs to fall into place for that $24.14 figure to work.
Result: Fair Value of $24.14 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Plains GP Holdings still faces concentration risk in crude oil demand and possible margin pressure if contract renewals or new projects do not support current assumptions.
Find out about the key risks to this Plains GP Holdings narrative.
The analyst narrative says Plains GP Holdings looks about 8.9% overvalued at $26.30 based on future earnings, yet the current P/S ratio is only 0.1x. That is far below the peer average of 3x and the fair ratio of 0.7x, which implies the market is pricing in a lot of business risk. Which signal do you treat as more important for your own thesis?
See what the numbers say about this price — find out in our valuation breakdown.
With Plains GP Holdings bringing together both risks and rewards in this story, it can be useful to promptly review the details yourself, then weigh the 3 key rewards and 1 important warning sign
If you stop with Plains GP Holdings, you risk missing other opportunities that fit your style. Use the Simply Wall St Screener to quickly surface fresh ideas that match your approach.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com